Page last updated: 2024-10-18

dimethyl sulfoxide and Lymphoma, Mantle-Cell

dimethyl sulfoxide has been researched along with Lymphoma, Mantle-Cell in 1 studies

Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.

Lymphoma, Mantle-Cell: A form of non-Hodgkin lymphoma having a usually diffuse pattern with both small and medium lymphocytes and small cleaved cells. It accounts for about 5% of adult non-Hodgkin lymphomas in the United States and Europe. The majority of mantle-cell lymphomas are associated with a t(11;14) translocation resulting in overexpression of the CYCLIN D1 gene (GENES, BCL-1).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haritunians, T1
Mori, A1
O'Kelly, J1
Luong, QT1
Giles, FJ1
Koeffler, HP1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase II Trial of RAD001 in Triple Negative Metastatic Breast Cancer[NCT00827567]Phase 26 participants (Actual)Interventional2009-04-30Terminated (stopped due to Slow accrual)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for dimethyl sulfoxide and Lymphoma, Mantle-Cell

ArticleYear
Antiproliferative activity of RAD001 (everolimus) as a single agent and combined with other agents in mantle cell lymphoma.
    Leukemia, 2007, Volume: 21, Issue:2

    Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Lin

2007